Forecasts by Product & Services (Assay, Kit, Software & Service, Software & Services), by Technology (PCR, ISH, NGS, IHC, Others (Multiplex Assay and Cellular Imaging Technologies)), by Indication (Cardiovascular, Neurological Diseases, Cancer, Infectious Diseases, Others (inflammatory and inherited diseases)), by End-User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, CROs, Others (Physicians, Hospitals, Academic Medical Centers, Payers) AND Regional and Leading National Market Analysis PLUS Analysis of Leading CDx Companies AND COVID-19 Recovery Scenarios
Want to Know What is holding you back in the Companion Diagnostics Business? Visiongain, a renowned market intelligence firm has published strategic report on ‘Global Companion Diagnostics Market’. This report explores the current and emerging opportunities in the Companion Diagnostics market. Companion diagnostic aids in identifying patients who are most likely to benefit from a particular therapeutic product. Growing precedence of companion diagnostics over traditional practice of “one-size-fits-all” therapies and accelerating demand for targeted therapy are increasing the adoption of companion diagnostics. However, high cost of developing companion diagnostic test is expected to thwart the market growth.
Huge Demand for Companion Diagnostics for cancer applications Significant adoption of companion diagnostics for cancer applications has been observed. Major companies and contract manufacturers such as Thermo Fisher Scientific and Roche provide companion diagnostic products for cancer in different countries. Thermo Fisher had launched Oncomine Dx Target Test for the detection of NSCLC. Additionally rising demand of personalized medicine and growing use of biomarkers for cancer diagnosis are expected to boost the demand.
Companion Diagnostics Market-our new study reveals current trends, technological advancements, and predicted revenues Where the Companion Diagnostics market is heading? If you are involved in this industry you must read this newly updated report. Visiongain’s report shows you the potential revenue streams to 2031, assessing data, trends, opportunities and business prospects there.
Owing to the COVID-19 pandemic, the supply chain and demand of Companion Diagnostics has been affected in 2020. But it is not just COVID-19 that affects the future of Companion Diagnostics. This unique senior report tells you what direction the market will take – and it tells you today.
Discover how to stay ahead Our 440+ page report provides 300+ tables, charts, and graphs.
Read on to discover the most lucrative areas in the industry and the future market prospects. Our study lets you assess forecasted sales at overall world market and regional level. See financial performance of companies, trends, opportunities, and revenue growth. Much opportunity remains in this growing Companion Diagnostics Market. See how to exploit the opportunities.
UNIQUE COVID-19 VARIATIONS– only available in this Visiongain report are dedicated analysis of 4 different rebound scenarios of how the market will develop – no matter how COVID-19 affects the economy.
Forecasts to 2030 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares, key player positioning, and an exhaustive product portfolio comparison of key vendors • You find original analyses, with business outlooks and developments which would be useful to tap potential business areas for key players • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges, SWOT analysis), product profiles and commercial developments.
Which Factors are Fuelling Companion Diagnostics Industry Growth? • Growing precedence of companion diagnostics over traditional practice of “one-size-fits-all” therapies • Accelerating demand for targeted therapy • Growing importance of personalized medicine to pave the way for companion diagnostic • Increasing global burden of cancer • Increase in scope of application of companion diagnostics
Which Factors are Restraining Growth? • High cost of developing companion diagnostic test to impede market growth • Challenges associated with uncertain reimbursement scenario in different regions
Forecasts to 2031 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares. • You find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, Porter’s Analysis, product profiles and commercial developments.
Report Scope Global Companion Diagnostics Market 2021-2031 is segmented on the basis of Product, Mode, End User and Geography.
Revenue and growth forecasts from 2021 to 2031 for the Global Companion Diagnostics Market by Products & Services: • Assay, Kit, Software & Service • Software & Services
Revenue and growth forecasts from 2021 to 2031 for the Global Companion Diagnostics Market by Technology: • PCR • ISH • NGS • IHC • Others
Revenue and growth forecasts from 2021 to 2031 for the Global Companion Diagnostics Market by Indication: • Cardiovascular • Neurological Diseases • Cancer • Infectious Diseases • Others
Revenue and growth forecasts from 2021 to 2031 for the Global Companion Diagnostics Market by End-User: • Pharmaceutical & Biopharmaceutical Companies • Reference Laboratories • CROs • Others
Revenue and growth forecasts from 2021 to 2031 for the Global Companion Diagnostics Market by Region:
• North America • U.S. • Canada
• Europe • Germany • France • UK • Italy • Spain • Switzerland • Rest of Europe
• Asia-Pacific • Japan • China • India • Australia • Rest of APAC
• Our study discusses the selected leading companies that are the major players in the Companion Diagnostics industry: • Roche • Agilent Technologies • Qiagen • Thermo Fisher • Abbott Laboratories • Almac Group • Danaher Corporation • Illmina • Biomurieux • Myriad Genetics • Sysmex Corporation • Guardant Health • Icon • Abnova Corporation • Biogenex Laboratories
How the Companion Diagnostics Market report helps you In summary, our 440+ page report provides you with the following knowledge: • What is the current size of the overall global Companion Diagnostics market? How much will this market be worth from 2021 to 2031? • What are the main drivers and restraints that will shape the overall Companion Diagnostics market over the next ten years? • What are the main segments within the overall Companion Diagnostics market? How much will each of these segments be worth for the period 2021 to 2031? How will the composition of the market change during that time, and why? • What factors will affect that industry and market over the next ten years? • Which are the leading companies and what are their activities, results, developments, and prospects? • What are the main trends that will affect the world Companion Diagnostics market between 2021 and 2031? • What are the main strengths, weaknesses, opportunities, and threats for the market? • How will the global Companion Diagnostics market evolve over the forecasted period, 2021 to 2031? • Revenue forecasts to 2030 for 4 regional and 10 key national markets – the report highlights market growth prospects for key countries such as the U.S., Canada, Germany, UK, France, Italy, Spain, Switzerland, China, Japan, Australia, and India. The report also highlights growth potential in Latin America as well as Middle East & Africa. • Prospects for established firms and those seeking to enter the market– including company profiles for over 15 of the major companies involved in the Companion Diagnostics market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Companion Diagnostics Market and leading companies. You will find data, trends and predictions.
Get our report today Companion Diagnostics Market Forecast 2021-2031: Forecast by Products and Services (assay & kit and software & services), by technology (PCR, ISH, NGS, IHC, and Others), by indications (cardiovascular, neurological diseases, cancer, infectious diseases, and others), by End User (pharmaceutical & biopharmaceutical companies, reference laboratories, CROs, and others), and By Region (North America, Europe, Asia Pacific, and LAMEA)
The Companion Diagnostics Market 2021-2031 report will be of value to anyone who wants to better understand the market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the digital healthcare industry.
Buy our report today Companion Diagnostics (CDx) Market Report 2021-2031: Forecasts by Product & Services (Assay, Kit, Software & Service, Software & Services), by Technology (PCR, ISH, NGS, IHC, Others (Multiplex Assay and Cellular Imaging Technologies)), by Indication (Cardiovascular, Neurological Diseases, Cancer, Infectious Diseases, Others (inflammatory and inherited diseases)), by End-User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, CROs, Others (Physicians, Hospitals, Academic Medical Centers, Payers) AND Regional and Leading National Market Analysis PLUS Analysis of Leading CDx Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1 Report Overview 1.1 Introduction to Global Companion Diagnostics Market 1.2 Global Companion Diagnostics Market Definition 1.3 Why You Should Read This Report 1.4 What This Report Delivers 1.5 Key Questions Answered By This Analytical Report Include: 1.6 Who is This Report For? 1.7 Methodology 1.7.1 Primary Research 1.7.2 Secondary Research 1.7.3 Market Evaluation & Forecasting Methodology 1.8 Frequently Asked Questions (FAQs) 1.9 Associated Visiongain Reports 1.10 About Visiongain
2 Executive Summary
3 Qualitative Analysis of the Global Companion Diagnostic Market 3.1 Market Dynamics 3.1.1 Drivers 3.1.1.1 Growing precedence of companion diagnostics over traditional practice of “one-size-fits-all” therapies 3.1.1.2 Accelerating demand for targeted therapy 3.1.1.3 Growing importance of personalized medicine to pave the way for companion diagnostic 3.1.1.4 Increasing global burden of cancer 3.1.1.5 Increase in scope of application of companion diagnostics 3.1.2 Restraints 3.1.2.1 High cost of developing companion diagnostic test to impede market growth 3.1.2.2 Challenges associated with uncertain reimbursement scenario in different regions 3.1.3 Opportunities 3.1.3.1 Upsurge in demand for next-generation sequencing based companion diagnostics 3.1.3.2 Growing significance of companion diagnostics as a powerful tool in drug discovery and development 3.1.3.3 Increasing number of clinical trials leading to inclusion of companion diagnostic 3.2 SWOT Analysis 3.3 PEST Analysis 3.3.1 Political 3.3.2 Economic 3.3.3 Sociocultural 3.3.4 Technological 3.4 Porter’s Five Forces Analysis 3.4.1 Moderate Bargaining Power of Supplier 3.4.2 High Bargaining Power of Buyer 3.4.3 Low Threat of New Entrants 3.4.4 High Threat of Substitutes 3.4.5 High Intensity of Competitive Rivalry 3.5 COVID-19 Impact Analysis 3.5.1 V-Shaped Recovery 3.5.2 U-Shaped Recovery 3.5.3 L-Shaped Recovery 3.5.4 W-Shaped Recovery
4 Global Companion Diagnostics Market, by Product & Services, 2021-2031 4.1 Global Companion Diagnostics Market Forecast by Product & Services, 2021-2031 4.2 Assays, Kits & Reagents 4.2.1 Increasing volume of CDX tests performed in laboratories to support the adoption of assays & kits 4.2.2 Global Companion Diagnostics Market for Assays, Kits & Reagents by Region: Market Forecast, 2021-2031 4.2.3 COVID-19 Impact on Global Companion Diagnostics Market Forecast for Assays, Kits & Reagents: Recovery Scenarios (V, U, W, L) 4.3 Software & Services 4.3.1 Need for effective data management software within laboratories to contribute to market growth. 4.3.2 Global Companion Diagnostics Market for Software & Services by Region: Market Forecast, 2021-2031 4.3.3 COVID-19 Impact on Global Companion Diagnostics Market Forecast for Software & Services: Recovery Scenarios (V, U, W, L)
5 Global Companion Diagnostics Market, by Technology, 2021-2031 5.1 Global Companion Diagnostics Market Forecast by Technology, 2021-2031 5.2 Polymerase Chain Reaction (PCR) 5.2.1 Growing applications of PCR technologies in personalized medicine and companion diagnostics to drive growth 5.2.2 Global Companion Diagnostics Market for Polymerase Chain Reaction (PCR) by Region: Market Forecast, 2021-2031 5.2.3 COVID-19 Impact on Global Companion Diagnostics Market For Polymerase Chain Reaction (PCR): Recovery Scenarios (V, U, W, L) 5.3 Next-Generation Sequencing (NSG) 5.3.1 Technological advancements and the high demand for NGS-based tests driving growth 5.3.2 Global Companion Diagnostics Market for Next-Generation Sequencing (NSG) by Region: Market Forecast, 2021-2031 5.3.3 COVID-19 Impact on Global Companion Diagnostics Market For Next-Generation Sequencing (NSG): Recovery Scenarios (V, U, W, L) 5.4 In Situ Hybridization (ISH) 5.4.1 Advancements in ISH and its demand in small-tumor diagnostics to drive growth 5.4.2 Global Companion Diagnostics Market for In Situ Hybridization (ISH) by Region: Market Forecast, 2021-2031 5.4.3 COVID-19 Impact on Global Companion Diagnostics Market For In Situ Hybridization (ISH): Recovery Scenarios (V, U, W, L) 5.5 Immunohistochemistry (IHC) 5.5.1 Increasing demand for user-friendly and cost-effective technologies in CDx to support growth in this segment 5.5.2 Global Companion Diagnostics Market for Immunohistochemistry (IHC) by Region: Market Forecast, 2021-2031 5.5.3 COVID-19 Impact on Global Companion Diagnostics Market For Immunohistochemistry (IHC): Recovery Scenarios (V, U, W, L) 5.6 Other Technologies 5.6.1 Global Companion Diagnostics Market for Other Technologies by Region: Market Forecast, 2021-2031 5.6.2 COVID-19 Impact on Global Companion Diagnostics Market For Other Technologies: Recovery Scenarios (V, U, W, L)
6 Global Companion Diagnostics Market, by Indication, 2021-2031 6.1 Global Companion Diagnostics Market Forecast by Indication, 2021-2031 6.2 Cancer 6.2.1 Breast cancer is the most common cancer among women which is a key factor contributing to the large share of this market segment 6.2.2 Global Companion Diagnostics Market for Cancer by Region: Market Forecast, 2021-2031 6.2.3 COVID-19 Impact on Global Companion Diagnostics Market For Cancer: Recovery Scenarios (V, U, W, L) 6.2.4 Breast Cancer 6.2.5 Lungs Cancer 6.2.6 Colorectal Cancer 6.2.7 Melanoma Cancer 6.2.8 Gastric Cancer 6.3 Infectious Disease 6.3.1 Growing focus of companion diagnostic players on orphan indications to propel the growth of this segment 6.3.2 Global Companion Diagnostics Market for Infectious Disease by Region: Market Forecast, 2021-2031 6.3.3 COVID-19 Impact on Global Companion Diagnostics Market For Infectious Disease: Recovery Scenarios (V, U, W, L) 6.4 Cardiovascular Diseases 6.4.1 Growing demand for targeted therapies due to high incidence of cardiovascular diseases to drive growth 6.4.2 Global Companion Diagnostics Market for Cardiovascular Diseases by Region: Market Forecast, 2021-2031 6.4.3 COVID-19 Impact on Global Companion Diagnostics Market For Cardiovascular Diseases: Recovery Scenarios (V, U, W, L) 6.5 Neurological Diseases 6.5.1 Growing number of diagnostic technologies for the treatment of neurological diseases to boost the adoption of companion diagnostics 6.5.2 Global Companion Diagnostics Market for Neurological Diseases by Region: Market Forecast, 2021-2031 6.5.3 COVID-19 Impact on Global Companion Diagnostics Market For Immunohistochemistry (IHC): Recovery Scenarios (V, U, W, L) 6.6 Other Indications 6.6.1 Global Companion Diagnostics Market for Other Indications by Region: Market Forecast, 2021-2031 6.6.2 COVID-19 Impact on Global Companion Diagnostics Market For Other Indications: Recovery Scenarios (V, U, W, L)
7 Global Companion Diagnostics Market, by End-User, 2021-2031 7.1 Global Companion Diagnostics Market Forecast by End-user, 2021-2031 7.2 Pharmaceutical & Biopharmaceutical Companies 7.2.1 Wide usage of CDx in pharmaceutical & biopharmaceutical companies to drive market growth 7.2.2 Global Companion Diagnostics Market for Pharmaceutical & Biopharmaceutical Companies by Region: Market Forecast, 2021-2031 7.2.3 COVID-19 Impact on Global Companion Diagnostics Market For Pharmaceutical & Biopharmaceutical Companies: Recovery Scenarios (V, U, W, L) 7.3 Reference Laboratories 7.3.1 Growing incidence of and rising demand for targeted therapies to drive growth 7.3.2 Global Companion Diagnostics Market for Reference Laboratories by Region: Market Forecast, 2021-2031 7.3.3 COVID-19 Impact on Global Companion Diagnostics Market For Reference Laboratories: Recovery Scenarios (V, U, W, L) 7.4 Contract Research Organizations (CRO) 7.4.1 CROs offer a complete range of companion diagnostic services to targeted therapy-related clinical trials 7.4.2 Global Companion Diagnostics Market for Contract Research Organizations (CRO) by Region: Market Forecast, 2021-2031 7.4.3 COVID-19 Impact on Global Companion Diagnostics Market For Contract Research Organizations (CRO): Recovery Scenarios (V, U, W, L) 7.5 Other End Users 7.5.1 Global Companion Diagnostics Market for Other End-User by Region: Market Forecast, 2021-2031 7.5.2 COVID-19 Impact on Global Companion Diagnostics Market For Other End-User: Recovery Scenarios (V, U, W, L)
8 Global Companion Diagnostics Market By Region, 2021-2031
9 North America Companion Diagnostics Market, 2021-2031 9.1.1 COVID-19 Impact on North America Companion Diagnostics Market: Recovery Scenarios (V, U, W, L) 9.2 North America Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 9.3 North America Companion Diagnostics Market Forecast, by Technology, 2021-2031 9.4 North America Companion Diagnostics Market Forecast, by Indication, 2021-2031 9.5 North America Companion Diagnostics Market Forecast, by End User, 2021-2031 9.6 North America Companion Diagnostics Market Forecast, by Country, 2021-2031 9.7 US 9.7.1 US is the largest market for companion diagnostics largely driven by advanced diagnostic technologies, and increasing demand for molecular diagnostic-based personalized medicine. 9.7.2 Increasing funding from Federal Government 9.7.3 U.S. Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 9.7.4 US Companion Diagnostics Market Forecast, by Technology, 2021-2031 9.7.5 US Companion Diagnostics Market Forecast, by Indication, 2021-2031 9.7.6 US Companion Diagnostics Market Forecast, by End User, 2021-2031 9.7.7 COVID-19 Impact on US Companion Diagnostics Market: Recovery Scenarios (V, U, W, L) 9.8 Canada 9.8.1 Rising incidence of chronic lifestyle diseases is expected to boost the market growth 9.8.2 Government initiatives to promote companion diagnostics in various indications to drive market growth in Canada. 9.8.3 Canada Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 9.8.4 Canada Companion Diagnostics Market Forecast, by Technology, 2021-2031 9.8.5 Canada Companion Diagnostics Market Forecast, by Indication, 2021-2031 9.8.6 Canada Companion Diagnostics Market Forecast, by End User, 2021-2031 9.8.7 COVID-19 Impact on Canada Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)
10 Europe Companion Diagnostics Market, 2021-2031 10.1.1 COVID-19 Impact on Europe Companion Diagnostics Market: Recovery Scenarios (V, U, W, L) 10.2 Europe Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 10.3 Europe Companion Diagnostics Market Forecast, by Technology, 2021-2031 10.4 Europe Companion Diagnostics Market Forecast, by Indication, 2021-2031 10.5 Europe Companion Diagnostics Market Forecast, by End User, 2021-2031 10.6 Europe Companion Diagnostics Market Forecast, by Country, 2021-2031 10.7 Germany 10.7.1 Growing geriatric population and incidence of chronic disease will boost the market 10.7.2 Germany is a major market for pharmaceutical and biotechnology products. 10.7.3 Germany Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 10.7.4 Germany Companion Diagnostics Market Forecast, by Technology, 2021-2031 10.7.5 Germany Companion Diagnostics Market Forecast, by Indication, 2021-2031 10.7.6 Germany Companion Diagnostics Market Forecast, by End User, 2021-2031 10.7.7 COVID-19 Impact on Germany Companion Diagnostics Market: Recovery Scenarios (V, U, W, L) 10.8 UK 10.8.1 Growth in the country’s life science industry is driving market growth in the UK. 10.8.2 Increasing R&D research will boost the market 10.8.3 UK Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 10.8.4 UK Companion Diagnostics Market Forecast, by Technology, 2021-2031 10.8.5 UK Companion Diagnostics Market Forecast, by Indication, 2021-2031 10.8.6 UK Companion Diagnostics Market Forecast, by End User, 2021-2031 10.8.7 COVID-19 Impact on UK Companion Diagnostics Market: Recovery Scenarios (V, U, W, L) 10.9 Switzerland 10.9.1 Presence of large research-based pharmaceutical industry 10.9.2 Switzerland boasts a strong research oriented pharma industry, a key factor supporting market growth. 10.9.3 Switzerland Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 10.9.4 Switzerland Companion Diagnostics Market Forecast, by Technology, 2021-2031 10.9.5 Switzerland Companion Diagnostics Market Forecast, by Indication, 2021-2031 10.9.6 Switzerland Companion Diagnostics Market Forecast, by End User, 2021-2031 10.9.7 COVID-19 Impact on Switzerland Companion Diagnostics Market: Recovery Scenarios (V, U, W, L) 10.10 France 10.10.1 Increasing government funding for genomics and personalized therapeutics R&D is driving market growth in France 10.10.2 Availability of reimbursement for cancer diagnostics 10.10.3 France Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 10.10.4 France Companion Diagnostics Market Forecast, by Technology, 2021-2031 10.10.5 France Companion Diagnostics Market Forecast, by Indication, 2021-2031 10.10.6 France Companion Diagnostics Market Forecast, by End User, 2021-2031 10.10.7 COVID-19 Impact on France Companion Diagnostics Market: Recovery Scenarios (V, U, W, L) 10.11 Italy 10.11.1 Growing disease prevalence has contributed to the demand for better, more powerful therapeutics in Italy. 10.11.2 Economic slowdown of Italian healthcare industry 10.11.3 Italy Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 10.11.4 Italy Companion Diagnostics Market Forecast, by Technology, 2021-2031 10.11.5 Italy Companion Diagnostics Market Forecast, by Indication, 2021-2031 10.11.6 Italy Companion Diagnostics Market Forecast, by End User, 2021-2031 10.11.7 COVID-19 Impact on Italy Companion Diagnostics Market: Recovery Scenarios (V, U, W, L) 10.12 Spain 10.12.1 Medical institutes in Spain are increasingly focusing on cancer biomarker research. 10.12.2 Presence of well-established network of research centers and healthcare organization 10.12.3 Spain Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 10.12.4 Spain Companion Diagnostics Market Forecast, by Technology, 2021-2031 10.12.5 Spain Companion Diagnostics Market Forecast, by Indication, 2021-2031 10.12.6 Spain Companion Diagnostics Market Forecast, by End User, 2021-2031 10.12.7 COVID-19 Impact on Spain Companion Diagnostics Market: Recovery Scenarios (V, U, W, L) 10.13 Rest of Europe 10.13.1 Rest of Europe Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 10.13.2 Rest of Europe Companion Diagnostics Market Forecast, by Technology, 2021-2031 10.13.3 Rest of Europe Companion Diagnostics Market Forecast, by Indication, 2021-2031 10.13.4 Rest of Europe Companion Diagnostics Market Forecast, by End User, 2021-2031 10.13.5 COVID-19 Impact on Rest of Europe Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)
11 Asia-Pacific Companion Diagnostics Market, 2021-2031 11.1.1 COVID-19 Impact on Asia-Pacific Companion Diagnostics Market: Recovery Scenarios (V, U, W, L) 11.2 Asia-Pacific Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 11.3 Asia-Pacific Companion Diagnostics Market Forecast, by Technology, 2021-2031 11.4 Asia-Pacific Companion Diagnostics Market Forecast, by Indication, 2021-2031 11.5 Asia-Pacific Companion Diagnostics Market Forecast, by End User, 2021-2031 11.6 Asia-Pacific Companion Diagnostics Market Forecast, by Country, 2021-2031 11.7 Japan 11.7.1 Japan holds the second largest share of the market in APAC majorly due to increasing demand for technologically advanced diagnostics. 11.7.2 Japan Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 11.7.3 Japan Companion Diagnostics Market Forecast, by Technology, 2021-2031 11.7.4 Japan Companion Diagnostics Market Forecast, by Indication, 2021-2031 11.7.5 Japan Companion Diagnostics Market Forecast, by End User, 2021-2031 11.7.6 COVID-19 Impact on Japan Companion Diagnostics Market: Recovery Scenarios (V, U, W, L) 11.8 China 11.8.1 The country’s large annual R&D investments and technological capabilities is anticipated to drive growth. 11.8.2 High incidence of chronic diseases 11.8.3 China Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 11.8.4 China Companion Diagnostics Market Forecast, by Technology, 2021-2031 11.8.5 China Companion Diagnostics Market Forecast, by Indication, 2021-2031 11.8.6 China Companion Diagnostics Market Forecast, by End User, 2021-2031 11.8.7 COVID-19 Impact on China Companion Diagnostics Market: Recovery Scenarios (V, U, W, L) 11.9 India 11.9.1 Government initiatives to tackle the growing burden of cancer and is expected to increase the adoption of CDX in the country. 11.9.2 Presence of large patient population 11.9.3 India Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 11.9.4 India Companion Diagnostics Market Forecast, by Technology, 2021-2031 11.9.5 India Companion Diagnostics Market Forecast, by Indication, 2021-2031 11.9.6 India Companion Diagnostics Market Forecast, by End User, 2021-2031 11.9.7 COVID-19 Impact on India Companion Diagnostics Market: Recovery Scenarios (V, U, W, L) 11.10 Australia 11.10.1 Growing geriatric population in Australia has resulted in initiatives to enhance healthcare access and infrastructure. 11.10.2 Increase in initiative of government research funding 11.10.3 Australia Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 11.10.4 Australia Companion Diagnostics Market Forecast, by Technology, 2021-2031 11.10.5 Australia Companion Diagnostics Market Forecast, by Indication, 2021-2031 11.10.6 Australia Companion Diagnostics Market Forecast, by End User, 2021-2031 11.10.7 COVID-19 Impact on Australia Companion Diagnostics Market: Recovery Scenarios (V, U, W, L) 11.11 Rest of APAC 11.11.1 Growing disease prevalence has contributed to the demand for better, more powerful therapeutics in Rest of APAC. 11.11.2 Rest of APAC Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 11.11.3 Rest of APAC Companion Diagnostics Market Forecast, by Technology, 2021-2031 11.11.4 Rest of APAC Companion Diagnostics Market Forecast, by Indication, 2021-2031 11.11.5 Rest of APAC Companion Diagnostics Market Forecast, by End User, 2021-2031 11.11.6 COVID-19 Impact on Rest of APAC Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)
12 Latin America, Middle East & Africa (LAMEA) Companion Diagnostics Market, 2021-2031 12.1.1 COVID-19 Impact on LAMEA Companion Diagnostics Market: Recovery Scenarios (V, U, W, L) 12.2 LAMEA Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 12.3 LAMEA Companion Diagnostics Market Forecast, by Technology, 2021-2031 12.4 LAMEA Companion Diagnostics Market Forecast, by Indication, 2021-2031 12.5 LAMEA Companion Diagnostics Market Forecast, by End User, 2021-2031 12.6 LAMEA Companion Diagnostics Market Forecast, by Country, 2021-2031 12.7 Brazil 12.7.1 Increase in the adoption of new and advanced delivery technologies, including IVD products driving growth. 12.7.2 Increase in incidence of chronic disease 12.7.3 Brazil Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 12.7.4 Brazil Companion Diagnostics Market Forecast, by Technology, 2021-2031 12.7.5 Brazil Companion Diagnostics Market Forecast, by Indication, 2021-2031 12.7.6 Brazil Companion Diagnostics Market Forecast, by End User, 2021-2031 12.7.7 COVID-19 Impact on Brazil Companion Diagnostics Market: Recovery Scenarios (V, U, W, L) 12.8 Mexico 12.8.1 Mexico is emerging as a prominent medical tourism hub. 12.8.2 Growing geriatric population 12.8.3 Mexico Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 12.8.4 Mexico Companion Diagnostics Market Forecast, by Technology, 2021-2031 12.8.5 Mexico Companion Diagnostics Market Forecast, by Indication, 2021-2031 12.8.6 Mexico Companion Diagnostics Market Forecast, by End User, 2021-2031 12.8.7 COVID-19 Impact on Mexico Companion Diagnostics Market: Recovery Scenarios (V, U, W, L) 12.9 Rest of LAMEA 12.9.1 Government initiatives to tackle the growing burden of cancer are expected to increase the adoption of CDX in the country. 12.9.2 Rest of LAMEA Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 12.9.3 Rest of LAMEA Companion Diagnostics Market Forecast, by Technology, 2021-2031 12.9.4 Rest of LAMEA Companion Diagnostics Market Forecast, by Indication, 2021-2031 12.9.5 Rest of LAMEA Companion Diagnostics Market Forecast, by End User, 2021-2031 12.9.6 COVID-19 Impact on Rest of LAMEA Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)
13 Company Profiles 13.1 Market Share Analysis 13.1.1 Companion Diagnostic Market: Market Share Analysis, 2020 13.2 Roche Diagnostics 13.2.1 Company Overview 13.2.2 Company Snapshot 13.2.3 Product Portfolio 13.2.4 Financial Analysis 13.2.4.1 Net Revenue, 2016-2020 13.2.4.2 Segmental Revenue Shares, 2020 13.2.4.3 Regional Revenue Shares, 2020 13.2.5 Recent Developments, 2017-2020 13.3 Agilent Technologies Inc. (US) 13.3.1 Company Overview 13.3.2 Company Snapshot 13.3.3 Product Portfolio 13.3.4 Financial Analysis Net Revenue, 2016-2020 13.3.4.1 Segmental Revenue Shares, 2020 13.3.4.2 Regional Revenue Shares, 2020 13.3.5 Recent Developments, 2018-2020 13.4 QIAGEN N.V. 13.4.1 Company Overview 13.4.2 Company Snapshot 13.4.3 Product Portfolio 13.4.4 Financial Analysis 13.4.4.1 Net Revenue, 2016-2020 13.4.4.2 Segmental Revenue Shares, 2020 13.4.4.3 Regional Revenue Shares, 2020 13.4.5 Recent Developments, 2018-2020 13.5 Thermo Fisher Scientific, Inc. 13.5.1 Company Overview 13.5.2 Company Snapshot 13.5.3 Product Portfolio 13.5.4 Financial Analysis 13.5.4.1 Net Revenue, 2016-2020 13.5.4.2 Segmental Revenue Shares, 2020 13.5.4.3 Regional Revenue Shares, 2020 13.5.5 Recent Developments, 2017-2020 13.6 ABBOTT LABORATORIES 13.6.1 Company Overview 13.6.2 Company Snapshot 13.6.3 Product Portfolio 13.6.4 Financial Analysis 13.6.4.1 Net Revenue, 2016-2020 13.6.4.2 Segmental Revenue Shares, 2020 13.6.4.3 Regional Revenue Shares, 2020 13.6.5 Recent Developments, 2020 13.7 ALMAC GROUP 13.7.1 Company Overview 13.7.2 Company Snapshot 13.7.3 Product Portfolio 13.7.4 Financial Analysis 13.7.4.1 Net Revenue, 2018-2019 13.7.5 Recent Developments, 2019 13.8 DANAHER CORPORATION 13.8.1 Company Overview 13.8.2 Company Snapshot 13.8.3 Product Portfolio 13.8.4 Financial Analysis 13.8.4.1 Net Revenue, 2016-2020 13.8.4.2 Segmental Revenue Shares, 2020 13.8.4.3 Regional Revenue Shares, 2019 13.8.5 Recent Developments, 2020 13.9 ILLUMINA INC. 13.9.1 Company Overview 13.9.2 Company Snapshot 13.9.3 Product Portfolio 13.9.4 Financial Analysis 13.9.4.1 Net Revenue, 2016-2020 13.9.4.2 Regional Revenue Shares, 2020 13.9.5 Recent Developments, 2017-2019 13.10 BIOMERIEUX SA 13.10.1 Company Overview 13.10.2 Company Snapshot 13.10.3 Product Portfolio 13.10.4 Financial Analysis 13.10.4.1 Net Revenue, 2015-2019 13.10.4.2 Segmental Revenue Shares, 2019 13.10.4.3 Regional Revenue Shares, 2019 13.10.5 Recent Developments, 2020 13.11 MYRIAD GENETICS, INC. 13.11.1 Company Overview 13.11.2 Company Snapshot 13.11.3 Product Portfolio 13.11.4 Financial Analysis 13.11.4.1 Net Revenue, 2016-2020 13.11.4.2 Segmental Revenue Shares, 2020 13.11.5 Recent Developments, 2017-2020 13.12 SYSMEX CORPORATION 13.12.1 Company Overview 13.12.2 Company Snapshot 13.12.3 Product Portfolio 13.12.4 Financial Analysis 13.12.4.1 Net Revenue, 2015-2019 13.12.4.2 Segmental Revenue Shares, 2019 13.12.4.3 Regional Revenue Shares, 2019 13.12.5 Recent Developments, 2018-2020 13.13 GUARDANT HEALTH, INC. 13.13.1 Company Overview 13.13.2 Company Snapshot 13.13.3 Product Portfolio 13.13.4 Financial Analysis 13.13.4.1 Net Revenue, 2016-2019 13.13.4.2 Segmental Revenue Shares, 2019 13.13.4.3 Regional Revenue Shares, 2019 13.13.5 Recent Developments, 2017-2018 13.14 ICON PLC 13.14.1 Company Overview 13.14.2 Company Snapshot 13.14.3 Product Portfolio 13.14.4 Financial Analysis 13.14.4.1 Net Revenue, 2016-2020 13.14.4.2 Regional Revenue Shares, 2020 13.14.5 Recent Developments, 2018 13.15 ABNOVA CORPORATION 13.15.1 Company Overview 13.15.2 Company Snapshot 13.15.3 Product Portfolio 13.15.4 Recent Developments, 2017 13.16 BIOGENEX LABORATORIES, INC 13.16.1 Company Overview 13.16.2 Company Snapshot 13.16.3 Product Portfolio
14 Conclusion and Recommendations 14.1 Concluding Remarks from Visiongain 14.2 Recommendations for Market Players 14.3 Leading Regions and Fastest Growing Region (Crisp Tagline with Market
List of Tables Table 2 Global Companion Diagnostic Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%): "V" Shaped Recovery Table 3 Global Companion Diagnostic Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%): "U" Shaped Recovery Table 4 Global Companion Diagnostic Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%): "L" Shaped Recovery Table 5 Global Companion Diagnostic Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%): "W" Shaped Recovery Table 1 Global Companion Diagnostics Market Forecast by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 2 Global Companion Diagnostics Market Forecast For Assays, Kits & Reagents by Region, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 3 Global Companion Diagnostics Market Forecast For Assays, Kits & Reagents, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery Table 4 Global Companion Diagnostics Market Forecast for Assays, Kits & Reagents, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery Table 5 Global Companion Diagnostics Market Forecast for Assays, Kits & Reagents, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery Table 6 Global Companion Diagnostics Market Forecast for Assays, Kits & Reagents, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery Table 7 Global Companion Diagnostics Market Forecast For Software & Services by Region, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 8 Global Companion Diagnostics Market Forecast For Software & Services, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery Table 9 Global Companion Diagnostics Market Forecast for Software & Services, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery Table 10 Global Companion Diagnostics Market Forecast for Software & Services, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery Table 11 Global Companion Diagnostics Market Forecast for Software & Services, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery Table 12 Global Companion Diagnostics Market Forecast by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 13 Global Companion Diagnostics Market Forecast For Polymerase Chain Reaction (PCR) by Region, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 14 Global Companion Diagnostics Market Forecast for Polymerase Chain Reaction (PCR), 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery Table 15 Global Companion Diagnostics Market Forecast for Polymerase Chain Reaction (PCR), 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery Table 16 Global Companion Diagnostics Market Forecast for Polymerase Chain Reaction (PCR), 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery Table 17 Global Companion Diagnostics Market Forecast for Polymerase Chain Reaction (PCR), 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery Table 18 Global Companion Diagnostics Market Forecast For Next-Generation Sequencing (NSG) by Region, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 19 Global Companion Diagnostics Market Forecast for Next-Generation Sequencing (NSG), 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery Table 20 Global Companion Diagnostics Market Forecast for Next-Generation Sequencing (NSG), 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery Table 21 Global Companion Diagnostics Market Forecast for Next-Generation Sequencing (NSG), 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery Table 22 Global Companion Diagnostics Market Forecast for Next-Generation Sequencing (NSG), 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery Table 23 Global Companion Diagnostics Market Forecast For In Situ Hybridization (ISH) by Region, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 24 Global Companion Diagnostics Market Forecast For In Situ Hybridization (ISH), 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery Table 25 Global Companion Diagnostics Market Forecast For In Situ Hybridization (ISH), 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery Table 26 Global Companion Diagnostics Market Forecast for In Situ Hybridization (ISH), 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery Table 27 Global Companion Diagnostics Market Forecast for In Situ Hybridization (ISH), 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery Table 28 Global Companion Diagnostics Market Forecast For Immunohistochemistry (IHC) by Region, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 29 Global Companion Diagnostics Market Forecast For Immunohistochemistry (IHC), 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery Table 30 Global Companion Diagnostics Market Forecast For Immunohistochemistry (IHC), 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery Table 31 Global Companion Diagnostics Market Forecast for Immunohistochemistry (IHC), 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery Table 32 Global Companion Diagnostics Market Forecast for Immunohistochemistry (IHC), 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery Table 33 Global Companion Diagnostics Market Forecast For Other Technologies by Region, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 34 Global Companion Diagnostics Market Forecast For Other Technologies, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery Table 35 Global Companion Diagnostics Market Forecast For Other Technologies, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery Table 36 Global Companion Diagnostics Market Forecast for Other Technologies, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery Table 37 Global Companion Diagnostics Market Forecast for Other Technologies, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery Table 38 Global Companion Diagnostics Market Forecast by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 39 Global Companion Diagnostics Market Forecast For Cancer by Region, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 40 Global Companion Diagnostics Market Forecast for Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery Table 41 Global Companion Diagnostics Market Forecast for Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery Table 42 Global Companion Diagnostics Market Forecast for Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery Table 43 Global Companion Diagnostics Market Forecast for Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery Table 44 Global Companion Diagnostics Market Forecast For Infectious Disease by Region, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 45 Global Companion Diagnostics Market Forecast for Infectious Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery Table 46 Global Companion Diagnostics Market Forecast for Infectious Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery Table 47 Global Companion Diagnostics Market Forecast for Infectious Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery Table 48 Global Companion Diagnostics Market Forecast for Infectious Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery Table 49 Global Companion Diagnostics Market Forecast For Cardiovascular Diseases by Region, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 50 Global Companion Diagnostics Market Forecast For Cardiovascular Diseases (ISH), 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery Table 51 Global Companion Diagnostics Market Forecast For Cardiovascular Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery Table 52 Global Companion Diagnostics Market Forecast for Cardiovascular Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery Table 53 Global Companion Diagnostics Market Forecast for Cardiovascular Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery Table 54 Global Companion Diagnostics Market Forecast For Neurological Diseases by Region, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 55 Global Companion Diagnostics Market Forecast For Neurological Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery Table 56 Global Companion Diagnostics Market Forecast For Neurological Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery Table 57 Global Companion Diagnostics Market Forecast for Neurological Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery Table 58 Global Companion Diagnostics Market Forecast for Neurological Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery Table 59 Global Companion Diagnostics Market Forecast For Other Indications by Region, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 60 Global Companion Diagnostics Market Forecast For Other Indications, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery Table 61 Global Companion Diagnostics Market Forecast For Other Indications, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery Table 62 Global Companion Diagnostics Market Forecast for Other Technologies, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery Table 63 Global Companion Diagnostics Market Forecast for Other Technologies, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery Table 64 Global Companion Diagnostics Market Forecast by End-User, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 65 Global Companion Diagnostics Market Forecast For Pharmaceutical & Biopharmaceutical Companies by Region, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 66 Global Companion Diagnostics Market Forecast for Pharmaceutical & Biopharmaceutical Companies, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery Table 67 Global Companion Diagnostics Market Forecast for Pharmaceutical & Biopharmaceutical Companies, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery Table 68 Global Companion Diagnostics Market Forecast for Pharmaceutical & Biopharmaceutical Companies, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery Table 69 Global Companion Diagnostics Market Forecast for Pharmaceutical & Biopharmaceutical Companies, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery Table 70 Global Companion Diagnostics Market Forecast For Reference Laboratories by Region, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 71 Global Companion Diagnostics Market Forecast for Reference Laboratories, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery Table 72 Global Companion Diagnostics Market Forecast for Reference Laboratories, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery Table 73 Global Companion Diagnostics Market Forecast for Reference Laboratories, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery Table 74 Global Companion Diagnostics Market Forecast for Reference Laboratories, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery Table 75 Global Companion Diagnostics Market Forecast For Contract Research Organizations (CRO) by Region, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 76 Global Companion Diagnostics Market Forecast For Contract Research Organizations (CRO), 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery Table 77 Global Companion Diagnostics Market Forecast For Contract Research Organizations (CRO), 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery Table 78 Global Companion Diagnostics Market Forecast for Contract Research Organizations (CRO), 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery Table 79 Global Companion Diagnostics Market Forecast for Contract Research Organizations (CRO), 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery Table 80 Global Companion Diagnostics Market Forecast For Other End-User by Region, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 81 Global Companion Diagnostics Market Forecast For Other End-User, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery Table 82 Global Companion Diagnostics Market Forecast For Other End-User, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery Table 83 Global Companion Diagnostics Market Forecast for Other End-User, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery Table 84 Global Companion Diagnostics Market Forecast for Other End-User, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery Table 85 Global Companion Diagnostic Market Forecast by Region, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 86 North America Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR Table 87 North America Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery Table 88 North America Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery Table 89 North America Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery Table 90 North America Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery Table 91 North America Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 92 North America Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 93 North America Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 94 North America Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 95 North America Companion Diagnostics Market Forecast, by Country, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 96 US Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 97 US Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 98 US Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 99 US Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 100 US Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery Table 101 US Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery Table 102 US Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery Table 103 US Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery Table 104 Canada Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 105 Canada Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 106 Canada Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 107 Canada Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 108 Canada Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery Table 109 Canada Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery Table 110 Canada Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery Table 111 Canada Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery Table 112 Europe Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR Table 113 Europe Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery Table 114 Europe Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery Table 115 Europe Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery Table 116 Europe Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery Table 117 Europe Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 118 Europe Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 119 Europe Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 120 Europe Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 121 Europe Companion Diagnostics Market Forecast, by Country, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 122 Germany Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 123 Germany Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 124 Germany Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 125 Germany Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 126 Germany Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery Table 127 Germany Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery Table 128 Germany Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery Table 129 Germany Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery Table 130 UK Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 131 UK Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 132 UK Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 133 UK Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 134 UK Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery Table 135 UK Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery Table 136 UK Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery Table 137 UK Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery Table 138 Switzerland Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 139 Switzerland Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 140 Switzerland Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 141 Switzerland Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 142 Switzerland Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery Table 143 Switzerland Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery Table 144 Switzerland Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery Table 145 Switzerland Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery Table 146 France Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 147 France Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 148 France Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 149 France Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 150 France Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery Table 151 France Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery Table 152 France Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery Table 153 France Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery Table 154 Italy Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 155 Italy Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 156 Italy Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 157 Italy Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 158 Italy Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery Table 159 Italy Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery Table 160 Italy Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery Table 161 Italy Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery Table 162 Spain Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 163 Spain Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 164 Spain Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 165 Spain Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 166 Spain Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery Table 167 Spain Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery Table 168 Spain Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery Table 169 Spain Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery Table 170 Rest of Europe Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 171 Rest of Europe Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 172 Rest of Europe Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 173 Rest of Europe Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 174 Rest of Europe Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery Table 175 Rest of Europe Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery Table 176 Rest of Europe Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery Table 177 Rest of Europe Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery Table 178 Asia-Pacific Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR Table 179 Asia-Pacific Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery Table 180 Asia-Pacific Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery Table 181 Asia-Pacific Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery Table 182 Asia-Pacific Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery Table 183 Asia-Pacific Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 184 Asia-Pacific Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 185 Asia-Pacific Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 186 Asia-Pacific Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 187 Asia-Pacific Companion Diagnostics Market Forecast, by Country, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 188 Japan Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 189 Japan Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 190 Japan Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 191 Japan Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 192 Japan Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery Table 193 Japan Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery Table 194 Japan Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery Table 195 Japan Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery Table 196 China Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 197 China Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 198 China Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 199 China Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 200 China Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery Table 201 China Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery Table 202 China Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery Table 203 China Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery Table 204 India Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 205 India Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 206 India Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 207 India Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 208 India Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery Table 209 India Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery Table 210 India Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery Table 211 India Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery Table 212 Australia Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 213 Australia Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 214 Australia Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 215 Australia Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 216 Australia Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery Table 217 Australia Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery Table 218 Australia Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery Table 219 Australia Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery Table 220 Rest of APAC Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 221 Rest of APAC Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 222 Rest of APAC Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 223 Rest of APAC Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 224 Rest of APAC Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery Table 225 Rest of APAC Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery Table 226 Rest of APAC Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery Table 227 Rest of APAC Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery Table 228 LAMEA Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR Table 229 LAMEA Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery Table 230 LAMEA Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery Table 231 LAMEA Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery Table 232 LAMEA Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery Table 233 LAMEA Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 234 LAMEA Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 235 LAMEA Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 236 LAMEA Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 237 LAMEA Companion Diagnostics Market Forecast, by Country, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 238 Brazil Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 239 Brazil Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 240 Brazil Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 241 Brazil Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 242 Brazil Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery Table 243 Brazil Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery Table 244 Brazil Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery Table 245 Brazil Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery Table 246 Mexico Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 247 Mexico Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 248 Mexico Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 249 Mexico Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 250 Mexico Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery Table 251 Mexico Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery Table 252 Mexico Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery Table 253 Mexico Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery Table 254 Rest of LAMEA Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 255 Rest of LAMEA Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 256 Rest of LAMEA Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 257 Rest of LAMEA Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%) Table 258 Rest of LAMEA Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery Table 259 Rest of LAMEA Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery Table 260 Rest of LAMEA Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery Table 261 Rest of LAMEA Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery
List of Figures Figure 1 Global Companion Diagnostics Market: SWOT Analysis Figure 2 Moderate Bargaining Power of Supplier Figure 3 High Bargaining Power of Buyer Figure 4 Low Threat of New Entrants Figure 5 Low Threat of Substitutes Figure 6 High Intensity Of Competitive Rivalry Figure 7 COVID-19 Impact on Companion Diagnostics Market (USD Billion), 2019-2031: V-Shaped Recovery Figure 8 COVID-19 Impact on Companion Diagnostics Market (USD Billion), 2019-2031: U-Shaped Recovery Figure 9 COVID-19 Impact on Companion Diagnostics Market (USD Billion), 2019-2031: L-Shaped Recovery Figure 10 COVID-19 Impact on Companion Diagnostics Market (USD Billion), 2019-2031: W-Shaped Recovery Figure 52 Global Companion Diagnostics Market Forecast by Region 2021-2031 (US$ billion) Figure 53 Global Companion Diagnostic Market Share Forecast by Region 2021, 2026, 2031 (%) Figure 54 North America Companion Diagnostics Market Forecast, 2021-2031 (US$ billion, AGR %) Figure 55 COVID-19 Impact on North America Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery Figure 56 COVID-19 Impact on North America Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery Figure 57 COVID-19 Impact on North America Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery Figure 58 COVID-19 Impact on North America Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery Figure 60 North America Companion Diagnostics Market Share Forecast, by Product& Services, 2021 and 2031 (%) Figure 62 North America Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%) Figure 64 North America Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%) Figure 66 North America Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%) Figure 68 North America Companion Diagnostics Market Share Forecast by Country, 2020, 2026, 2031 (%) Figure 69 US Companion Diagnostics Market Share Forecast, by Product & Services, 2020, 2026, 2031 (%) Figure 70 US Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%) Figure 71 US Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%) Figure 72 US Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%) Figure 73 COVID-19 Impact on US Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery Figure 74 COVID-19 Impact on US Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery Figure 75 COVID-19 Impact on US Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery Figure 76 COVID-19 Impact on US Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery Figure 77 Canada Companion Diagnostics Market Share Forecast, by Product & Services, 2020, 2026, 2031 (%) Figure 78 Canada Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%) Figure 79 Canada Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%) Figure 80 Canada Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%) Figure 81 COVID-19 Impact on Canada Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery Figure 82 COVID-19 Impact on Canada Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery Figure 83 COVID-19 Impact on Canada Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery Figure 84 COVID-19 Impact on Canada Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery Figure 85 Europe Companion Diagnostics Market Forecast, 2021-2031 (US$ billion, AGR %) Figure 86 COVID-19 Impact on Europe Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery Figure 87 COVID-19 Impact on Europe Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery Figure 88 COVID-19 Impact on Europe Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery Figure 89 COVID-19 Impact on Europe Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery Figure 91 Europe Companion Diagnostics Market Share Forecast, by Product& Services, 2021 and 2031 (%) Figure 2 Europe Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%) Figure 2 Europe Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%) Figure 4 Europe Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%) Figure 6 Europe Companion Diagnostics Market Share Forecast by Country, 2020, 2026, 2031 (%) Figure 7 Germany Companion Diagnostics Market Share Forecast, by Product & Services, 2020, 2026, 2031 (%) Figure 8 Germany Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%) Figure 9 Germany Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%) Figure 10 Germany Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%) Figure 11 COVID-19 Impact on Germany Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery Figure 12 COVID-19 Impact on Germany Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery Figure 13 COVID-19 Impact on Germany Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery Figure 14 COVID-19 Impact on Germany Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery Figure 15 UK Companion Diagnostics Market Share Forecast, by Product & Services, 2020, 2026, 2031 (%) Figure 16 UK Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%) Figure 17 UK Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%) Figure 18 UK Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%) Figure 19 COVID-19 Impact on UK Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery Figure 20 COVID-19 Impact on UK Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery Figure 21 COVID-19 Impact on UK Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery Figure 22 COVID-19 Impact on UK Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery Figure 23 Switzerland Companion Diagnostics Market Share Forecast, by Product & Services, 2020, 2026, 2031 (%) Figure 24 Switzerland Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%) Figure 25 Switzerland Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%) Figure 26 Switzerland Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%) Figure 27 COVID-19 Impact on Switzerland Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery Figure 28 COVID-19 Impact on Switzerland Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery Figure 29 COVID-19 Impact on Switzerland Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery Figure 30 COVID-19 Impact on Switzerland Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery Figure 31 France Companion Diagnostics Market Share Forecast, by Product & Services, 2020, 2026, 2031 (%) Figure 32 France Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%) Figure 33 France Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%) Figure 34 France Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%) Figure 35 COVID-19 Impact on France Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery Figure 36 COVID-19 Impact on France Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery Figure 37 COVID-19 Impact on France Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery Figure 38 COVID-19 Impact on France Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery Figure 39 Italy Companion Diagnostics Market Share Forecast, by Product & Services, 2020, 2026, 2031 (%) Figure 40 Italy Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%) Figure 41 Italy Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%) Figure 42 Italy Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%) Figure 43 COVID-19 Impact on Italy Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery Figure 45 COVID-19 Impact on Italy Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery Figure 46 COVID-19 Impact on Italy Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery Figure 47 Spain Companion Diagnostics Market Share Forecast, by Product & Services, 2020, 2026, 2031 (%) Figure 48 Spain Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%) Figure 49 Spain Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%) Figure 50 Spain Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%) Figure 51 COVID-19 Impact on Spain Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery Figure 52 COVID-19 Impact on Spain Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery Figure 53 COVID-19 Impact on Spain Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery Figure 54 COVID-19 Impact on Spain Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery Figure 55 Rest of Europe Companion Diagnostics Market Share Forecast, by Product & Services, 2020, 2026, 2031 (%) Figure 56 Rest of Europe Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%) Figure 57 Rest of Europe Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%) Figure 58 Rest of Europe Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%) Figure 59 COVID-19 Impact on Rest of Europe Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery Figure 60 COVID-19 Impact on Rest of Europe Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery Figure 61 COVID-19 Impact on Rest of Europe Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery Figure 62 COVID-19 Impact on Rest of Europe Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery Figure 63 Asia-Pacific Companion Diagnostics Market Forecast, 2021-2031 (US$ billion, AGR %) Figure 64 COVID-19 Impact on Asia-Pacific Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery Figure 65 COVID-19 Impact on Asia-Pacific Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery Figure 66 COVID-19 Impact on Asia-Pacific Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery Figure 67 COVID-19 Impact on Asia-Pacific Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery Figure 69 Asia-Pacific Companion Diagnostics Market Share Forecast, by Product& Services, 2021 and 2031 (%) Figure 71 Asia-Pacific Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%) Figure 73 Asia-Pacific Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%) Figure 74 Asia-Pacific Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%) Figure 76 Asia-Pacific Companion Diagnostics Market Share Forecast by Country, 2020, 2026, 2031 (%) Figure 77 Japan Companion Diagnostics Market Share Forecast, by Product & Services, 2020, 2026, 2031 (%) Figure 78 Japan Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%) Figure 79 Japan Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%) Figure 80 Japan Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%) Figure 81 COVID-19 Impact on Japan Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery Figure 82 COVID-19 Impact on Japan Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery Figure 83 COVID-19 Impact on Japan Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery Figure 84 COVID-19 Impact on Japan Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery Figure 85 China Companion Diagnostics Market Share Forecast, by Product & Services, 2020, 2026, 2031 (%) Figure 86 China Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%) Figure 87 China Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%) Figure 88 China Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%) Figure 89 COVID-19 Impact on China Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery Figure 90 COVID-19 Impact on China Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery Figure 91 COVID-19 Impact on China Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery Figure 92 COVID-19 Impact on China Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery Figure 93 India Companion Diagnostics Market Share Forecast, by Product & Services, 2020, 2026, 2031 (%) Figure 94 India Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%) Figure 95 India Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%) Figure 96 India Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%) Figure 97 COVID-19 Impact on India Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery Figure 98 COVID-19 Impact on India Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery Figure 99 COVID-19 Impact on India Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery Figure 100 COVID-19 Impact on India Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery Figure 101 Australia Companion Diagnostics Market Share Forecast, by Product & Services, 2020, 2026, 2031 (%) Figure 102 Australia Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%) Figure 103 Australia Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%) Figure 104 Australia Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%) Figure 105 COVID-19 Impact on Australia Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery Figure 106 COVID-19 Impact on Australia Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery Figure 108 COVID-19 Impact on Australia Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery Figure 109 Rest of APAC Companion Diagnostics Market Share Forecast, by Product & Services, 2020, 2026, 2031 (%) Figure 110 Rest of APAC Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%) Figure 111 Rest of APAC Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%) Figure 112 Rest of APAC Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%) Figure 113 COVID-19 Impact on Rest of APAC Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery Figure 114 COVID-19 Impact on Rest of APAC Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery Figure 115 COVID-19 Impact on Rest of APAC Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery Figure 116 COVID-19 Impact on Rest of APAC Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery Figure 117 LAMEA Companion Diagnostics Market Forecast, 2021-2031 (US$ billion, AGR %) Figure 118 COVID-19 Impact on LAMEA Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery Figure 119 COVID-19 Impact on LAMEA Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery Figure 120 COVID-19 Impact on LAMEA Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery Figure 121 COVID-19 Impact on LAMEA Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery Figure 123 LAMEA Companion Diagnostics Market Share Forecast, by Product& Services, 2021 and 2031 (%) Figure 125 LAMEA Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%) Figure 127 LAMEA Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%) Figure 129 LAMEA Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%) Figure 131 LAMEA Companion Diagnostics Market Share Forecast by Country, 2020, 2026, 2031 (%) Figure 132 Brazil Companion Diagnostics Market Share Forecast, by Product & Services, 2020, 2026, 2031 (%) Figure 133 Brazil Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%) Figure 134 Brazil Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%) Figure 135 Brazil Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%) Figure 136 COVID-19 Impact on Brazil Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery Figure 137 COVID-19 Impact on Brazil Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery Figure 138 COVID-19 Impact on Brazil Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery Figure 139 COVID-19 Impact on Brazil Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery Figure 140 Mexico Companion Diagnostics Market Share Forecast, by Product & Services, 2020, 2026, 2031 (%) Figure 141 Mexico Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%) Figure 142 Mexico Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%) Figure 143 Mexico Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%) Figure 144 COVID-19 Impact on Mexico Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery Figure 145 COVID-19 Impact on Mexico Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery Figure 146 COVID-19 Impact on Mexico Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery Figure 147 COVID-19 Impact on Mexico Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery Figure 148 Rest of LAMEA Companion Diagnostics Market Share Forecast, by Product & Services, 2020, 2026, 2031 (%) Figure 149 Rest of LAMEA Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%) Figure 150 Rest of LAMEA Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%) Figure 151 Rest of LAMEA Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%) Figure 152 COVID-19 Impact on Rest of LAMEA Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery Figure 153 COVID-19 Impact on Rest of LAMEA Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery Figure 154 COVID-19 Impact on Rest of LAMEA Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery Figure 155 COVID-19 Impact on Rest of LAMEA Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery Figure 156 Market Share Analysis, 2020 Figure 157 ROCHE DIAGNOSTICS (SWITZERLAND): Net Revenue, 2016-2020 (US$ million, AGR%) Figure 158 ROCHE DIAGNOSTICS (SWITZERLAND): Segmental Revenue Shares 2020 Figure 159 ROCHE DIAGNOSTICS (SWITZERLAND): Regional Revenue Shares 2020 Figure 160 AGILENT TECHNOLOGIES, INC (US): Net Revenue, 2017-2020 (US$ million, AGR%) Figure 161 AGILENT TECHNOLOGIES, INC (US): Segmental Revenue Shares 2020 Figure 162 Agilent Technologies, Inc (US): Regional Revenue Shares 2020 Figure 163 QIAGEN N.V.: Net Revenue, 2016-2020 (US$ million, AGR%) Figure 164 QIAGEN N.V.: Segmental Revenue Shares 2020 Figure 165 QIAGEN N.V.: Regional Revenue Shares 2020 Figure 166 THERMO FISHER SCIENTIFIC, INC: Net Revenue, 2016-2020 (US$ million, AGR%) Figure 167 THERMO FISHER SCIENTIFIC, INC: Segmental Revenue Shares 2020 Figure 168 THERMO FISHER SCIENTIFIC, INC: Regional Revenue Shares 2020 Figure 169 ABBOTT LABORATORIES INC: Net Revenue, 2016-2020 (US$ million, AGR%) Figure 170 ABBOTT LABORATORIES INC: Segmental Revenue Shares 2020 Figure 171 ABBOTT LABORATORIES INC: Regional Revenue Shares 2020 Figure 172 ALMAC GROUP: Net Revenue, 2018-2019 (US$ million, AGR%) Figure 173 Danaher Corporation: Net Revenue, 2016-2020 (US$ million, AGR%) Figure 174 Danaher Corporation: Segmental Revenue Shares 2020 Figure 175 Danaher Corporation: Regional Revenue Shares 2019 Figure 177 Illumina Inc.: Regional Revenue Shares 2020 Figure 178 Biomreieux SA: Net Revenue, 2017-2020 (US$ million, AGR%) Figure 179 Biomreieux SA: Segmental Revenue Shares 2019 Figure 180 Biomreieux SA: Regional Revenue Shares 2019 Figure 181 Myriad Genetics Inc.: Net Revenue, 2016-2020 (US$ million, AGR%) Figure 182 Myriad Genetics Inc.: Segmental Revenue Shares 2020 Figure 183 Sysmex Corporation: Net Revenue, 2015-2019 (US$ million, AGR%) Figure 184 Sysmex Corporation: Segmental Revenue Shares 2019 Figure 185 Sysmex Corporation: Regional Revenue Shares 2019 Figure 186 Guardant Health Inc.: Net Revenue, 2016-2019 (US$ million, AGR%) Figure 187 Guardant Health Inc.: Segmental Revenue Shares 2019 Figure 188 Guardant Health Inc.: Regional Revenue Shares 2019 Figure 190 ICON PLC: Regional Revenue Shares 2020
Companies Profiled in the Report: Abbott Laboratories, Inc. (US) Abnova Corporation (Taiwan) Agilent Technologies, Inc. (US) Almac Group (UK) Biogenex Laboratories, Inc. (US) bioMérieux SA (France) Danaher Corporation (US) Guardant Health, Inc. (US) Icon Plc (Ireland) Illumina, Inc. (US) Myriad Genetics, Inc., (US) QIAGEN N.V. (Germany) Roche Diagnostic (Switzerland) Sysmex Corporation (Japan) Thermo Fisher Scientific Inc. (US)
List of Other Companies: 20/20 Gene Systems Abbott Molecular Affymetrix Agilent (Dako) Ambry Genetics Amgen Arca bipharma Arno Astellas Pharma AstraZeneca Asuragen Bayer Biomonitor Boehringer Ingelheim Brain Resource Company Bristol-Myers Squibb Cancer Research UK CancerGuide Diagnostics Caprion Proteomics Caris Life Sciences Celera (acquired by Quest Diagnostics) Celgene Cepheid ChemGenex Pharmaceuticals Clarient Clinical Reference Laboratory Clovis College of American Pathology (CAP) CompanDx Crescendo Bioscience Curidium Medica Dako (Agilent) Deloitte DiagnoCure Dx assays DxS Eli Lilly Endocyte European Medicines Agency (EMA) Exosome Diagnostics Ferring Flagship Biosciences FlowMetric Diagnostics Foundation Medical Foundation Medicine Genentech Genfit Genia Technologies Genmab GenMark Diagnostics Gilead Sciences GlaxoSmithKline GSK Hexie Health HistologiX Idera ImmunoGen Incyte InDex Pharmaceuticals IntegraGen Inverness Medical Innovations (now known as Alere) Invivoscribe Technologies Ipsen Ipsogen IQuum Janssen Pharmaceutical Kimball Genetics (a division of LabCorp) Kunlun Health Insurance Lab Corp Lab21 Laboratory for Personalized Molecular Medicine Leica Leica Biosystems Leica Micosystems Life Technologies Medical Research Council Medicare MedImmune (AstraZeneca) Merck Merck Serono MolecularMD Monogram Biosciences Myriad RBM Nanosphere Nanostring NanoString Technologies National Health Insurance (NHI) (South Korea) NIH Northern Institute for Cancer Research Novartis Oxford BioTherapeutics (earlier Oxford Genome Sciences) Pacific Diagnostics Clinical Laboratory (ResearchDx) Pfizer PICC Health Insurance Ping An Insurance Group Prionics Progenika Biopharma Prometheus Protagen Protagen Diagnostics Quintiles Quintiles Transnational Corporation Randox Pharma Services ResearchDx Resonance Health Resonance Health Analysis Services RiboMed Biotechnologies Rule-Based Medicine Saladax Biomedical ServizioSanitarioNazionale (SSN) Siemens Siemens Healthcare Signal Genetics Sirius Genomics Sistema Único de Saúde (SUS) Skyline Diagnostics Solvay Innogenetics Takeda’s Millennium unit Target Discovery TcLand Expression TESARO The Association of British Pharmaceutical Industries The Food and Drug Administration (FDA) The Haute Autorité de santé (HAS) The National Institute for Health and Care Excellence (NICE) Theranostics (NZ) Theranostics Health Third Wave Technologies (Hologic) TIB MolBiol Tocagen Tragara Pharmaceuticals Transgenomic TRICARE TrimGen Corporation Tufts Center for the Study of Drug Development Unilabs University of Newcastle Ventana Medical Systems (a subsidiary of Roche) ViiV Healthcare Weisenthal Cancer Group
List of Organizations Mentioned in the Report: American Association of Cancer Research (AACR) Asian cancer Research Group (ACRG) Association of Australian Medical Research Institutes (AAMRI) Brazilian National Cancer Institute (INCA) Center for Drug Evaluation and Research (CDER) Center for Medicare and Medicaid Services (CMS) Economic and Public Health Evaluation Committee (CEPS) European Medical Agency (EMA) Food and Drug Administration (FDA) French National Authority for Health Genomics Expert Network for enterprises (GENE) Genomics Expert Network for enterprises (GENE) Global Cancer Observatory (GLOBOCAN) Indian Council of Medical Research (ICMR) International Agency Tor Research on Cancer (IARC) Joint United Nations Programme on HIV and AIDS (UNAIDS) Lilly Singapore Centre for Drug Discovery (LSCDD) Macmillan Cancer Support MDCG: Medical Device Co-ordination Group Medical Device Co-ordination Group (MDCG) National Accrediting Agency report for Clinical Laboratory sciences (NAACLS) National Cancer institute (NCI) National Center for Biotechnology Information (NCBI) National Institute of Cancer (INCa) Personalized Medicine working Group (PMWG) Pharmaceuticals and Medical Devices Agency (PMDA) Spanish National R&D Plan Spanish society of Anatomic Pathology (SEAP) Spanish Society of Medical Oncology (SEOM) Spanish Society of Medical Oncology (SEOM) U.S. Department of Agriculture (USDA) World Cancer Research Fund World health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Companion Diagnostics (CDx) Market Report 2021-2031
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
